Allogene Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PFIZER INC | 02/12/2026 | 22.03 M | $30.18 M | 0.00% | 9.92% |
| TPG GP A, LLC | 02/13/2026 | 18.72 M | $25.64 M | 0.00% | 8.43% |
| BLACKROCK, INC. | 02/12/2026 | 17.68 M | $24.22 M | 0.92% | 7.96% |
| CITADEL ADVISORS LLC | 02/17/2026 | 12.11 M | $16.59 M | -13.31% | 5.45% |
| VANGUARD GROUP INC | 01/29/2026 | 9.25 M | $12.67 M | 2.56% | 4.17% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 8.14 M | $11.15 M | 14.98% | 3.67% |
| PATIENT SQUARE CAPITAL LP | 02/12/2026 | 4.96 M | $6.80 M | 66.49% | 2.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.93 M | $5.39 M | 2.58% | 1.77% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 3.87 M | $5.30 M | 0.00% | 1.74% |
| WOODLINE PARTNERS LP | 02/17/2026 | 3.50 M | $4.80 M | -19.72% | 1.58% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 3.42 M | $4.69 M | 1.18% | 1.54% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.21 M | $4.40 M | -12.73% | 1.45% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 02/03/2026 | 2.92 M | $4.00 M | 0.00% | 1.32% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 2.89 M | $3.96 M | 3.90% | 1.30% |
| STATE STREET CORP | 02/13/2026 | 2.76 M | $3.78 M | 0.22% | 1.24% |
| 02/13/2026 | 2.55 M | $3.49 B | 100.00% | 1.15% | |
| CANDRIAM S.C.A. | 02/13/2026 | 2.31 M | $3.16 M | 100.00% | 1.04% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 2.29 M | $3.14 M | 90.20% | 1.03% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.19 M | $3.00 M | -24.42% | 0.99% |
| JANE STREET GROUP, LLC | 02/12/2026 | 2.16 M | $2.96 M | 77.70% | 0.97% |
| ABRDN PLC | 01/16/2026 | 2.09 M | $2.86 M | 31.86% | 0.94% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.84 M | $2.52 M | -45.68% | 0.83% |
| FMR LLC | 02/17/2026 | 1.45 M | $1.98 M | 103.35% | 0.65% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.43 M | $1.96 M | -22.89% | 0.64% |
| UBS GROUP AG | 01/29/2026 | 1.39 M | $1.90 M | -61.09% | 0.63% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.38 M | $1.89 M | 0.00% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.36 M | $1.86 M | 16.35% | 0.61% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.28 M | $1.76 M | 176.56% | 0.58% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.20 M | $1.64 M | -6.34% | 0.54% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.01 M | $1.38 M | 3.39% | 0.45% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 995.14 K | $1.36 M | 86.42% | 0.45% |
| JPMORGAN CHASE & CO | 02/11/2026 | 979.11 K | $1.34 M | 7.75% | 0.44% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 957.82 K | $1.31 M | -54.19% | 0.43% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 900.42 K | $1.23 M | 0.68% | 0.41% |
| RAIFFEISEN BANK INTERNATIONAL AG | 02/12/2026 | 900.00 K | $1.18 M | 100.00% | 0.41% |
| MORGAN STANLEY | 02/13/2026 | 703.14 K | $963.30 K | -45.88% | 0.32% |
| BARCLAYS PLC | 02/13/2026 | 642.69 K | $880.48 K | 7.29% | 0.29% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 614.00 K | $841.00 K | 235.74% | 0.28% |
| INVESCO LTD. | 02/19/2026 | 609.81 K | $835.44 K | 16.08% | 0.27% |
| CITIGROUP INC | 02/13/2026 | 591.95 K | $810.97 K | -0.36% | 0.27% |
| MAN GROUP PLC | 02/17/2026 | 526.11 K | $720.77 K | 86.53% | 0.24% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 484.62 K | $637.83 K | -1.09% | 0.22% |
| XTX TOPCO LTD | 02/17/2026 | 476.31 K | $652.54 K | -38.48% | 0.21% |
| IEQ CAPITAL, LLC | 02/13/2026 | 435.27 K | $596.32 K | 15.74% | 0.20% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 414.07 K | $567.28 K | 0.00% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 405.84 K | $556.01 K | 0.99% | 0.18% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 296.50 K | $406.20 K | 0.00% | 0.13% |
| MARSHALL WACE, LLP | 02/13/2026 | 285.56 K | $391.22 K | 100.00% | 0.13% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 274.42 K | $375.95 K | 15.33% | 0.12% |
| CREATIVE PLANNING | 02/17/2026 | 273.38 K | $374.54 K | 409.76% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Allogene Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 222 institutional investors and hedge funds held shares of Allogene Therapeutics Inc. The most heavily invested institutionals were:
PFIZER INC: 22.03 M
TPG GP A, LLC: 18.72 M
BlackRock, Inc.: 17.68 M
CITADEL ADVISORS LLC: 12.11 M
VANGUARD GROUP INC: 9.25 M
PRIMECAP MANAGEMENT CO/CA/: 8.14 M
44.72% of Allogene Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 197.76 M shares in the last 24 months. This purchase volume represents approximately $405.40 M in transactions.